MT DPHHS Diabetes Program Presents Montana Diabetes Professional Conference

MT DPHHS Diabetes Program PresentsMontana Diabetes Professional Conference

Agenda

The webinar recording will be posted (without CEs) on November 2nd. Please check back.

2021 - Printable Agenda

Links to slides, handouts, or resources (if any) will be posted in the table below. 

Click here for the Session Descriptions & Speaker Bios.

2021 Virtual Conference Agenda

Friday, October 8 (MDT)

8:00 - 8:10 am

Welcome and Announcements

8:10 – 8:30 am

100 Years of Insulin - Montana Diabetes Program

8:30 – 9:45 am

The Natural History of Cardiometabolic Disease - Neil Kaminsky, MD, Endocrinology, Diabetes & Metabolism Specialist, Albuquerque, NM    Presentation Slides-PDF

9:45 – 11:00 am

Diabetes and Covid-19: Emerging evidence regarding risk, prognosis, management, practical considerations and impact of the viral pandemicAlana Barber, MSN, FNP-BC, BC-ADM, Family Nurse Practitioner, St. Vincent Healthcare, MT       Presentation Slides-PDF

11:00 – 11:15 am

Break

11:15 am – 12:30 pm

Understanding and Addressing Problematic Medication Adherence in Diabetes Care - William H. Polonsky, PhD, CDCES President, Behavioral Diabetes Institute, Associate Clinical Professor - University of California, CA    Presentation Slides-PDF

12:30 – 1:15 pm

Lunch Break

1:15 – 2:30 pm

Management of Hypoglycemia in Diabetic Patients - Michael J. Clare-Salzler, M.D., Professor Emeritus, Department of Pathology, Immunology and Laboratory Medicine - University of Florida College of Medicine, FL   Presentation Slides - PDF

2:30 – 2:45 pm

Break

2:45 – 4:00 pm

New Technologies to Improve Diabetes Care - Diana Isaacs, PharmD, BCPS, BC-ADM, CDE, Endocrine Clinical Pharmacy Specialist - Cleveland Clinic, OH     Presentation Slides-PDF

4:00 – 4:15 pm

Recognition & Awards - MT Diabetes Program

4:15 – 4:30 pm

Closure & Evaluation

Objective

Upon completion of this activity, attendees should be able to: 
Identify at least one way to more effectively function as a member of a team providing care to a patient with diabetes using current evidence-based data.

Disclosures

Planning Committee: Alyssa Johnson, Melissa House, Jessie Fernandes, Marci Butcher, Susan Day, and Michelle Eckert
Speakers: Neil Kaminsky, Alana Barber, William H. Polonsky, Diana Isaacs, and Michael J. Clare-Salzler

There is no conflict of interest for anyone in a position to control the content of this activity, except for William H. Polonsky who is a consultant for Dexcom, Abbott, Insulet, Intuity, Novo Nordisk, Sanofi, and Eli Lilly, and Diana Isaacs who is on the speaker’s bureau for Novo Nordisk, Insulet, Dexcom, Abbott, Medtronic.